Thomas J P, Thomson W H
Br Med J (Clin Res Ed). 1983 Jun 25;286(6383):2015-8. doi: 10.1136/bmj.286.6383.2015.
The biochemical disturbance produced by thiazide diuretics and by amiloride during treatment of moderate hypertension were compared. Two parallel studies were initiated. In one 40 patients with newly diagnosed hypertension were treated with metoprolol and a diuretic, either hydrochlorothiazide or amiloride. In a second study 38 patients receiving longstanding treatment with hypotensives and thiazides either continued the treatment or replaced the thiazide with amiloride. Initial biochemical assessments were compared with those after two years in the study. In previously untreated patients, thiazide produced a significant fall in plasma potassium and hyperuricaemia that did not occur with amiloride (p less than 0.001). Those patients receiving long term treatment for their hypertension who continued to take thiazides had persistent hypokalaemia and hyperuricaemia. Substitution with amiloride corrected the hypokalaemia and serum uric acid returned toward normal ranges, but this change was not statistically significant. Patients receiving long term treatment also had impaired glucose tolerance, this remained unchanged in those receiving thiazide but was corrected in those receiving amiloride. Compared with amiloride thiazides produced undesirable but reversible biochemical changes. As control of hypertension was equally effective with both preparations, we suggest that a combination of amiloride with a beta blocker in treatment of moderate hypertension in preferred.
比较了噻嗪类利尿剂和阿米洛利在治疗中度高血压期间所产生的生化紊乱情况。开展了两项平行研究。在一项研究中,40例新诊断的高血压患者接受美托洛尔和一种利尿剂治疗,利尿剂为氢氯噻嗪或阿米洛利。在第二项研究中,38例长期接受降压药和噻嗪类药物治疗的患者要么继续治疗,要么用阿米洛利替代噻嗪类药物。将初始生化评估结果与研究两年后的结果进行比较。在未经治疗的患者中,噻嗪类药物导致血浆钾显著下降和高尿酸血症,而阿米洛利未出现这种情况(p<0.001)。那些接受高血压长期治疗且继续服用噻嗪类药物的患者存在持续性低钾血症和高尿酸血症。用阿米洛利替代后纠正了低钾血症,血清尿酸恢复至正常范围,但这种变化无统计学意义。接受长期治疗的患者还存在糖耐量受损,服用噻嗪类药物的患者这种情况未改变,但服用阿米洛利的患者得到了纠正。与阿米洛利相比,噻嗪类药物产生了不良但可逆的生化变化。由于两种制剂对高血压的控制同样有效,我们建议在治疗中度高血压时,优先选用阿米洛利与β受体阻滞剂联合使用。